The Next Decade of Aesthetics Is Regenerative — Here's Why I Built REGEN for It

Every few years, aesthetics quietly redraws itself. We had the volume era — bigger lips, fuller cheeks, structural filler used to a fault. We had the toxin era, where anti-wrinkle became routine. We are now entering what I think will be the most clinically interesting decade the field has produced: the regenerative era.

Regenerative aesthetics is not a marketing phrase. It is a clinically distinct way of working. Instead of redistributing tissue or relaxing muscle, the treatments in this category ask the skin to behave better — to produce more collagen, repair its own damage, hydrate from within, restore its barrier and rebuild the underlying structure. The result is a face that ages slowly and quietly, without ever looking treated. That is the outcome the better clients have always wanted, and it is the outcome we have built REGEN around from the day we opened.

What "regenerative aesthetics" actually means

A regenerative treatment, in the way I use the term in my clinic, has three properties.

It signals the skin's own machinery — fibroblasts, dermal papilla cells, growth-factor pathways — to do something it can already do, just better. It does not introduce a foreign volume that has to be maintained or eventually dissolved. And it produces a result that improves over months, not minutes — because real tissue change is biological, and biology takes time.

The current short list, all of which we use in clinic:

• Profhilo — bio-remodelling hyaluronic acid that hydrates the skin from within and stimulates collagen and elastin production
• Polynucleotides — short DNA fragments that drive cellular repair, particularly impressive around the eyes, neck, jawline and scalp
• Platelet-Rich Plasma (PRP) — growth factors taken from your own blood, used for skin quality and (in the right cases) hair restoration
• Medical microneedling, often layered with growth factors or PRP serum, to drive controlled collagen remodelling
• Medical-grade chemical peels, sequenced to skin type, to reset the surface and accelerate turnover

These are not new individually. What is new is the body of evidence supporting them, the precision of the protocols, and the cultural appetite for outcomes that look like glow rather than work.

Why this shift is happening now

Three things have moved at once.

The science has caught up. We now understand more clearly how dermal papilla stretching influences hair growth genes, how moderate-pressure stimulation supports parasympathetic recovery, how polynucleotide fragments interact with fibroblast behaviour. The mechanism stories are tighter than they were five years ago.

The technology has improved. Microneedling devices are calibrated, growth-factor and exosome formulations are more refined, and the delivery systems for biologically active molecules into the dermis are better than they have ever been.

And the client has changed. Clients are now suspicious of overt change. They want subtle, sustainable, plausible. The treatments that fit that brief are the regenerative ones — almost by definition, because their results unfold quietly.

What this means for how I treat in clinic

In a regenerative practice, the questions in the consultation are different. We are no longer asking what should we add to your face. We are asking what does your skin need to start behaving like itself again. That changes the prescription. It pushes us towards layered protocols across months rather than single-session interventions. It means I see clients more often — but each visit does less, and the long-term result is more flattering.

It also means we lean harder on assessment. There is no point in running a regenerative protocol without first understanding what is actually limiting the skin's behaviour. The Reveal Consultation is where that assessment happens.

The next ten years

I think we will see regenerative treatments become the default first-line of aesthetic care for clients in their thirties and forties — instead of, or alongside, the more traditional volume and toxin routes. I expect exosomes, when the regulatory and evidence picture is clearer, to take a larger role. I expect home-care lines to integrate more directly with in-clinic regenerative protocols. And I expect the clients who have spent the last decade chasing visible change to quietly migrate towards subtle, durable skin quality.

That is the territory we built REGEN around. The clinic exists to do this kind of work, properly, in a setting that respects the time it takes to make real change.

If this is how you want to think about your skin — long-term, biologically, without theatrics — that conversation starts with a Reveal Consultation.